View Item 

Show simple item record

Amiodarone in Pediatric Patients
dc.contributor.authorDick, Macdonald IIen_US
dc.contributor.authorScott, William A.en_US
dc.date.accessioned2010-06-01T22:10:10Z
dc.date.available2010-06-01T22:10:10Z
dc.date.issued1986-12en_US
dc.identifier.citationDICK, MACDONALD; SCOTT, WILLIAM A. (1986). "Amiodarone in Pediatric Patients." Journal of Cardiovascular Electrophysiology 4(6): 522-527. <http://hdl.handle.net/2027.42/75189>en_US
dc.identifier.issn1045-3873en_US
dc.identifier.issn1540-8167en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/75189
dc.format.extent3671889 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights1986 Futura Publishing Company, Inc.en_US
dc.subject.otherPharmacokineticsen_US
dc.subject.otherSide Effectsen_US
dc.subject.otherSupra Ventricular Tachycardiaen_US
dc.subject.otherVentricular Fibrillationen_US
dc.subject.otherVentricular Tachycardiaen_US
dc.titleAmiodarone in Pediatric Patientsen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbsecondlevelPhysiologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumFrom the Division of Pediatric Cardiology, C.S. Mott Children's Hospital, and the Department of Pediatrics, University of Michigan Medical School, Ann Arbor, Michiganen_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/75189/1/j.1540-8167.1986.tb01730.x.pdf
dc.identifier.doi10.1111/j.1540-8167.1986.tb01730.xen_US
dc.identifier.sourceJournal of Cardiovascular Electrophysiologyen_US
dc.identifier.citedreferenceDick, M., and Campbell, R.M.: Advances in the management of cardiac arrhythmias in children. Pediatr. din. North Am., 31: 1175, 1984.en_US
dc.identifier.citedreferenceSingh, B.N., and Vaughn Williams, E.M.,: The effects of amiodarone, a new anti-anginal drug, on cardiac muscle. Br. J. Pharmacol, 39: 657, 1970.en_US
dc.identifier.citedreferenceTuna, I.C., Qi, A., Gornick, C, et al.: Kinetics of electro physiologic changes during oral loading of amiodarone and after withdrawal of amiodaione in the unsedated dog. Circulation, 72: 1380, 1985.en_US
dc.identifier.citedreferenceMorady, R, DiCarlo, L.A., Krol, R.B., et al.: Acute and chronic effects of amiodarone in ventricular refractoriness, inter ventricular conduction and ventricular tachycardia induction. J. Am. Coll. Cardiol., 7: 148, 1986.en_US
dc.identifier.citedreferenceYabek, S.M., Kato, R., and Singh, B.N.: Acute effects of amiodarone on the electro physiologic properties of isolated neonatal and adult cardiac fibers, J. Am. Coll. Cardiol., 5: 1109, 1985.en_US
dc.identifier.citedreferenceCoumel, P., and Fidelle, J.: Amiodarone in the treatment of cardiac arrhythmias in children: One hundred thirty-five cases. Am. Heart J., 100: 1063, 1980.en_US
dc.identifier.citedreferenceGarson, A., Gillette, P.C., and McVey, P.: Amiodarone treatment of critical arrhythmias in children and young adults. J. Am. Coll. Cardiol., 4: 749, 1984,.en_US
dc.identifier.citedreferenceLatini, R, Tognoni, G., and Kates, R.E.; Clinical pharmacokinetics of amiodarone Clin.. Pharmacokinetics, 9: 136, 1984.en_US
dc.identifier.citedreferenceRotmensch, H.H., Belhassen, B., Swanson, B.N., et al.: Steady-state serum amiodarone concentrations: Relationships with annarrhythmic efficacy and toxicity. Ann. Intern. Med., 10: 462, 1984.en_US
dc.identifier.citedreferenceRaeder, E.A., Podrid, P.J., and Lown, B.: Side effects and complications of amiodarone therapy. Am. Heart J., 109: 975, 1985.en_US
dc.identifier.citedreferenceTorres, V., Tepper, D., Flowers, D., et al.: QT prolongation and the anti arrhythmic efficacy of amiodarone. J. Am. Coll. Cardiol., 7: 142, 1986.en_US
dc.identifier.citedreferenceRey, E. Duperron, L., Gauthier, R., et al.: Transplacental treatment of tachycardia-induced fetal heart failure with verapamil and amiodarone: A case report. Am. J. Obstet. Gynecol, 153: 311, 1985.en_US
dc.identifier.citedreferencePenn, I.M., Barrett, PA., Pannikote, V., et al.: Amiodarone in pregnancy. Am. J. Cardiol., 56: 196, 1985.en_US
dc.identifier.citedreferenceWellens, H.J.J., Lie, K.I., Bar, F.W., et al.: Effect of amiodarone in the Wolff-Parkinson-White syndrome. Am. J. Cardiol., 38: 189, 1976.en_US
dc.identifier.citedreferenceRosenbaum, M.B., Chiale, P.A., Halpern, M.S., et al.: Clinical efficacy of amiodarone as an anti arrhythmic agent. Am. J. Cardiol., 58: 934, 1976.en_US
dc.identifier.citedreferenceShahar, E., Barzilay, Z., Frand, M., et al.: Amiodarone in control of sustained tachyarrhythmias in children with Wolff-Parkinson-White syndrome. Pediatrics, 72: 813, 1983.en_US
dc.identifier.citedreferenceGarson, A., and Gillette PC.: Junctional ectopic tachycardia in children: Electrocardiography, electro physiology and pharmacologic response. Am. J. Cardiol., 44: 298, 1979.en_US
dc.identifier.citedreferenceMorady, F., Sauve, M.J., Malone, P., et al.: Long-term efficacy and toxicity of high-dose amiodarone therapy for ventricular tachycardia or ventricular fibrillation. Am. J. Cardiol., 52: 975, 1983.en_US
dc.identifier.citedreferenceHeger, J.J., Prystowsky, E.N., Jackman, W.M., et al.: Amiodarone: Clinical efficacy and electro physiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation. N. Engl. J. Mad., 305: 539, 1981.en_US
dc.identifier.citedreferenceFogoros, R.N., Anderson, K.P., Winkle, R.A., et al.: Amiodarone: Clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias. Circulation, 68: 88, 1983.en_US
dc.identifier.citedreferencePickoff, A.S., Singh, S., Flinn, C.J., et al.: Use of amiodarone in the therapy of primary ventricular arrhythmias in children. Dm Pharmacol. Ther., 6: 73, 1983.en_US
dc.identifier.citedreferenceSmith, W.M., Lubbe, W.F., Whitlock, R.M., et al.: Long-term tolerance of amiodarone treatment for cardiac arrhythmias. Am. J. Cardiol, 57: 1288, 1986.en_US
dc.identifier.citedreferenceCharness, M.E., Morady, E, Scheinman, M.M.: Frequent neurologic toxicity associated with amiodarone therapy Neurology, 669, 1984.en_US
dc.identifier.citedreferenceYagupsky, P., Gonzala, E., Sofer, S., et al.: Fatal hepatic failure and encephalopathy associated with amiodarone. J. Pediatr., 107: 967, 1985.en_US
dc.identifier.citedreferenceCostigan, D.C., Holland, F.J., Daneman, D., et al.: Amiodarone therapy effects on childhood thyroid function. Pediatrics, 77. 703, 1986.en_US
dc.identifier.citedreferenceKoren, G., Hesslein, P.S., and MacLeod, S.M.: Digoxin toxicity associated wth amiodarone therapy in children. J. Pediatr., 104: 467, 1984.en_US
dc.identifier.citedreferenceMarcus, F.I.: Drug interactions with amiodarone. Am. Heart J., 106: 924, 1983.en_US
dc.identifier.citedreferenceHamer, A., Peter, T., Mandel, W.J., et al.: The potentiation of warfarin anticoagulation by amiodarone. Circulation, 65: 1025, 1982.en_US
dc.identifier.citedreferenceNademanee, K., Singh, B.N., Hendrickson, J.A., et al.: Pharmacokinetic significance of serum reverse T 3 levels during amiodarone treatment: A potential method for monitoring chronic drug therapy. Circulation, 66: 202, 1982.en_US
dc.identifier.citedreferenceStrasberg, B., Davidson, E., and Berand, M.: Amiodarone-induced sinorrial block. Int. J. Cardiol, 8: 214, 1985.en_US
dc.identifier.citedreferenceZeevi, B., Berant, M., Sclarovsky, S., et al.: Treatment of multi focal atrial tachycardia with amiodarone in a child with congenital heart disease. Am. J. Cardiol, 57: 344, 1986.en_US
dc.identifier.citedreferenceCoumel, P., Lucet, V., and Ngoc, D.D.: The use of amiodarone in children. PACE, 6: 930, 1983.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1540-8167.1986.tb01730.x.pdf
Size:
3.501MB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.